バイオ医薬品の世界市場 2024-2028

概要

バイオ医薬品市場は2023-2028年に2,040億9,000万米ドル、予測期間中のCAGRは7.98%で成長すると予測されます。

当レポートでは、バイオ医薬品市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、健康障害の有病率の増加、高齢者人口の増加、生物製剤の標的治療メカニズムなどによって牽引されています。

本調査では、今後数年間におけるバイオ医薬品市場の成長を牽引する主な要因の1つとして、ワクチン生産の増加を挙げています。また、ライフサイエンス分野への投資の増加やベンダーによる買収の増加も、市場の大きな需要につながると見込まれています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• バイオ医薬品の世界市場 2018-2022
• 製品セグメント分析 2018-2022
• 用途別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• モノクローナル抗体：市場規模と予測 2023-2028
• 組換えの成長因子：市場規模と予測 2023-2028
• ワクチン：市場規模と予測 2023-2028
• 組換えのホルモン：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：製品別

第7章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• 腫瘍学：市場規模と予測 2023-2028
• 自己免疫疾患：市場規模と予測 2023-2028
• 代謝異常：市場規模と予測 2023-2028
• ホルモン障害：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：用途別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Amgen Inc.
• Astellas Pharma Inc.
• AstraZeneca Plc
• Bayer AG
• Biogen Inc.
• Bristol Myers Squibb Co.
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• Johnson and Johnson
• Novartis AG
• Novo Nordisk AS
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Application
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global bio-pharma market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Product - Market share 2023-2028 (%)
• Exhibits31: Data Table on Product - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Product
• Exhibits33: Data Table on Comparison by Product
• Exhibits34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
• Exhibits43: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
• Exhibits44: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
• Exhibits46: Chart on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
• Exhibits47: Data Table on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
• Exhibits48: Chart on Recombinant hormones - Year-over-year growth 2023-2028 (%)
• Exhibits49: Data Table on Recombinant hormones - Year-over-year growth 2023-2028 (%)
• Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits54: Market opportunity by Product ($ billion)
• Exhibits55: Data Table on Market opportunity by Product ($ billion)
• Exhibits56: Chart on Application - Market share 2023-2028 (%)
• Exhibits57: Data Table on Application - Market share 2023-2028 (%)
• Exhibits58: Chart on Comparison by Application
• Exhibits59: Data Table on Comparison by Application
• Exhibits60: Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
• Exhibits61: Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
• Exhibits62: Chart on Oncology - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibits65: Data Table on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibits66: Chart on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
• Exhibits68: Chart on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibits69: Data Table on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibits70: Chart on Metabolic disorder - Year-over-year growth 2023-2028 (%)
• Exhibits71: Data Table on Metabolic disorder - Year-over-year growth 2023-2028 (%)
• Exhibits72: Chart on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibits73: Data Table on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibits74: Chart on Hormonal disorder - Year-over-year growth 2023-2028 (%)
• Exhibits75: Data Table on Hormonal disorder - Year-over-year growth 2023-2028 (%)
• Exhibits76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits78: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits79: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits80: Market opportunity by Application ($ billion)
• Exhibits81: Data Table on Market opportunity by Application ($ billion)
• Exhibits82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits83: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits85: Chart on Geographic comparison
• Exhibits86: Data Table on Geographic comparison
• Exhibits87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits105: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits109: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits113: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits115: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits116: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits117: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits118: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits121: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits123: Market opportunity By Geographical Landscape ($ billion)
• Exhibits124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits125: Impact of drivers and challenges in 2023 and 2028
• Exhibits126: Overview on Criticality of inputs and Factors of differentiation
• Exhibits127: Overview on factors of disruption
• Exhibits128: Impact of key risks on business
• Exhibits129: Vendors covered
• Exhibits130: Matrix on vendor position and classification
• Exhibits131: AbbVie Inc. - Overview
• Exhibits132: AbbVie Inc. - Product / Service
• Exhibits133: AbbVie Inc. - Key news
• Exhibits134: AbbVie Inc. - Key offerings
• Exhibits135: Amgen Inc. - Overview
• Exhibits136: Amgen Inc. - Product / Service
• Exhibits137: Amgen Inc. - Key offerings
• Exhibits138: Astellas Pharma Inc. - Overview
• Exhibits139: Astellas Pharma Inc. - Product / Service
• Exhibits140: Astellas Pharma Inc. - Key news
• Exhibits141: Astellas Pharma Inc. - Key offerings
• Exhibits142: AstraZeneca Plc - Overview
• Exhibits143: AstraZeneca Plc - Product / Service
• Exhibits144: AstraZeneca Plc - Key news
• Exhibits145: AstraZeneca Plc - Key offerings
• Exhibits146: Bayer AG - Overview
• Exhibits147: Bayer AG - Business segments
• Exhibits148: Bayer AG - Key news
• Exhibits149: Bayer AG - Key offerings
• Exhibits150: Bayer AG - Segment focus
• Exhibits151: Biogen Inc. - Overview
• Exhibits152: Biogen Inc. - Product / Service
• Exhibits153: Biogen Inc. - Key offerings
• Exhibits154: Bristol Myers Squibb Co. - Overview
• Exhibits155: Bristol Myers Squibb Co. - Product / Service
• Exhibits156: Bristol Myers Squibb Co. - Key news
• Exhibits157: Bristol Myers Squibb Co. - Key offerings
• Exhibits158: Eli Lilly and Co. - Overview
• Exhibits159: Eli Lilly and Co. - Product / Service
• Exhibits160: Eli Lilly and Co. - Key news
• Exhibits161: Eli Lilly and Co. - Key offerings
• Exhibits162: F. Hoffmann La Roche Ltd. - Overview
• Exhibits163: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits164: F. Hoffmann La Roche Ltd. - Key news
• Exhibits165: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits166: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits167: Johnson and Johnson - Overview
• Exhibits168: Johnson and Johnson - Business segments
• Exhibits169: Johnson and Johnson - Key news
• Exhibits170: Johnson and Johnson - Key offerings
• Exhibits171: Johnson and Johnson - Segment focus
• Exhibits172: Novartis AG - Overview
• Exhibits173: Novartis AG - Business segments
• Exhibits174: Novartis AG - Key offerings
• Exhibits175: Novartis AG - Segment focus
• Exhibits176: Novo Nordisk AS - Overview
• Exhibits177: Novo Nordisk AS - Business segments
• Exhibits178: Novo Nordisk AS - Key offerings
• Exhibits179: Novo Nordisk AS - Segment focus
• Exhibits180: Pfizer Inc. - Overview
• Exhibits181: Pfizer Inc. - Product / Service
• Exhibits182: Pfizer Inc. - Key news
• Exhibits183: Pfizer Inc. - Key offerings
• Exhibits184: Sanofi SA - Overview
• Exhibits185: Sanofi SA - Business segments
• Exhibits186: Sanofi SA - Key news
• Exhibits187: Sanofi SA - Key offerings
• Exhibits188: Sanofi SA - Segment focus
• Exhibits189: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits190: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits191: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits192: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits193: Inclusions checklist
• Exhibits194: Exclusions checklist
• Exhibits195: Currency conversion rates for US$
• Exhibits196: Research methodology
• Exhibits197: Validation techniques employed for market sizing
• Exhibits198: Information sources
• Exhibits199: List of abbreviations

Abstract

The bio-pharma market is forecasted to grow by USD 204.09 bn during 2023-2028, accelerating at a CAGR of 7.98% during the forecast period. The report on the bio-pharma market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of health disorders, the growing geriatric population, and the targeted therapeutic mechanism of biologics.

Technavio's bio-pharma market is segmented as below:

By Product

• Monoclonal antibodies
• Recombinant growth factors
• Vaccines
• Recombinant hormones
• Others

By Application

• Oncology
• Autoimmune disorder
• Metabolic disorder
• Hormonal disorder
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rise in the production of vaccines as one of the prime reasons driving the bio-pharma market growth during the next few years. Also, growing investments in the life sciences sector and a growing number of acquisitions by market vendors will lead to sizable demand in the market.

The report on the bio-pharma market covers the following areas:

• Bio-pharma market sizing
• Bio-pharma market forecast
• Bio-pharma market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bio-pharma market vendors that include AbbVie Inc., Amgen Inc., Angelini S.p.a., AspenBio, Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Ipsen Pharma, Johnson and Johnson, Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Vertex Pharmaceuticals Inc.. Also, the bio-pharma market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global bio-pharma market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global bio-pharma market 2018 - 2022 ($ billion)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• 4.3 Application Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Monoclonal antibodies - Market size and forecast 2023-2028
• Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
• 6.4 Recombinant growth factors - Market size and forecast 2023-2028
• Exhibit 38: Chart on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
• 6.5 Vaccines - Market size and forecast 2023-2028
• Exhibit 42: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
• 6.6 Recombinant hormones - Market size and forecast 2023-2028
• Exhibit 46: Chart on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
• Exhibit 47: Data Table on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
• Exhibit 48: Chart on Recombinant hormones - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Recombinant hormones - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
• Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Product
• Exhibit 54: Market opportunity by Product ($ billion)
• Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 56: Chart on Application - Market share 2023-2028 (%)
• Exhibit 57: Data Table on Application - Market share 2023-2028 (%)
• 7.2 Comparison by Application
• Exhibit 58: Chart on Comparison by Application
• Exhibit 59: Data Table on Comparison by Application
• 7.3 Oncology - Market size and forecast 2023-2028
• Exhibit 60: Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Oncology - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
• 7.4 Autoimmune disorder - Market size and forecast 2023-2028
• Exhibit 64: Chart on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Data Table on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibit 66: Chart on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
• 7.5 Metabolic disorder - Market size and forecast 2023-2028
• Exhibit 68: Chart on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Data Table on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibit 70: Chart on Metabolic disorder - Year-over-year growth 2023-2028 (%)
• Exhibit 71: Data Table on Metabolic disorder - Year-over-year growth 2023-2028 (%)
• 7.6 Hormonal disorder - Market size and forecast 2023-2028
• Exhibit 72: Chart on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Data Table on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
• Exhibit 74: Chart on Hormonal disorder - Year-over-year growth 2023-2028 (%)
• Exhibit 75: Data Table on Hormonal disorder - Year-over-year growth 2023-2028 (%)
• 7.7 Others - Market size and forecast 2023-2028
• Exhibit 76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 78: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 79: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.8 Market opportunity by Application
• Exhibit 80: Market opportunity by Application ($ billion)
• Exhibit 81: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 83: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 85: Chart on Geographic comparison
• Exhibit 86: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 103: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
• Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
• Exhibit 115: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 116: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 117: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 118: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 121: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 125: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 127: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 128: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 129: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 130: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 131: AbbVie Inc. - Overview
• Exhibit 132: AbbVie Inc. - Product / Service
• Exhibit 133: AbbVie Inc. - Key news
• Exhibit 134: AbbVie Inc. - Key offerings
• 12.4 Amgen Inc.
• Exhibit 135: Amgen Inc. - Overview
• Exhibit 136: Amgen Inc. - Product / Service
• Exhibit 137: Amgen Inc. - Key offerings
• 12.5 Astellas Pharma Inc.
• Exhibit 138: Astellas Pharma Inc. - Overview
• Exhibit 139: Astellas Pharma Inc. - Product / Service
• Exhibit 140: Astellas Pharma Inc. - Key news
• Exhibit 141: Astellas Pharma Inc. - Key offerings
• 12.6 AstraZeneca Plc
• Exhibit 142: AstraZeneca Plc - Overview
• Exhibit 143: AstraZeneca Plc - Product / Service
• Exhibit 144: AstraZeneca Plc - Key news
• Exhibit 145: AstraZeneca Plc - Key offerings
• 12.7 Bayer AG
• Exhibit 146: Bayer AG - Overview
• Exhibit 147: Bayer AG - Business segments
• Exhibit 148: Bayer AG - Key news
• Exhibit 149: Bayer AG - Key offerings
• Exhibit 150: Bayer AG - Segment focus
• 12.8 Biogen Inc.
• Exhibit 151: Biogen Inc. - Overview
• Exhibit 152: Biogen Inc. - Product / Service
• Exhibit 153: Biogen Inc. - Key offerings
• 12.9 Bristol Myers Squibb Co.
• Exhibit 154: Bristol Myers Squibb Co. - Overview
• Exhibit 155: Bristol Myers Squibb Co. - Product / Service
• Exhibit 156: Bristol Myers Squibb Co. - Key news
• Exhibit 157: Bristol Myers Squibb Co. - Key offerings
• 12.10 Eli Lilly and Co.
• Exhibit 158: Eli Lilly and Co. - Overview
• Exhibit 159: Eli Lilly and Co. - Product / Service
• Exhibit 160: Eli Lilly and Co. - Key news
• Exhibit 161: Eli Lilly and Co. - Key offerings
• 12.11 F. Hoffmann La Roche Ltd.
• Exhibit 162: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 163: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 164: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 165: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 166: F. Hoffmann La Roche Ltd. - Segment focus
• 12.12 Johnson and Johnson
• Exhibit 167: Johnson and Johnson - Overview
• Exhibit 168: Johnson and Johnson - Business segments
• Exhibit 169: Johnson and Johnson - Key news
• Exhibit 170: Johnson and Johnson - Key offerings
• Exhibit 171: Johnson and Johnson - Segment focus
• 12.13 Novartis AG
• Exhibit 172: Novartis AG - Overview
• Exhibit 173: Novartis AG - Business segments
• Exhibit 174: Novartis AG - Key offerings
• Exhibit 175: Novartis AG - Segment focus
• 12.14 Novo Nordisk AS
• Exhibit 176: Novo Nordisk AS - Overview
• Exhibit 177: Novo Nordisk AS - Business segments
• Exhibit 178: Novo Nordisk AS - Key offerings
• Exhibit 179: Novo Nordisk AS - Segment focus
• 12.15 Pfizer Inc.
• Exhibit 180: Pfizer Inc. - Overview
• Exhibit 181: Pfizer Inc. - Product / Service
• Exhibit 182: Pfizer Inc. - Key news
• Exhibit 183: Pfizer Inc. - Key offerings
• 12.16 Sanofi SA
• Exhibit 184: Sanofi SA - Overview
• Exhibit 185: Sanofi SA - Business segments
• Exhibit 186: Sanofi SA - Key news
• Exhibit 187: Sanofi SA - Key offerings
• Exhibit 188: Sanofi SA - Segment focus
• 12.17 Takeda Pharmaceutical Co. Ltd.
• Exhibit 189: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 190: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 191: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 192: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 193: Inclusions checklist
• Exhibit 194: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 195: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 196: Research methodology
• Exhibit 197: Validation techniques employed for market sizing
• Exhibit 198: Information sources
• 13.5 List of abbreviations
• Exhibit 199: List of abbreviations